Outcomes and Prognostic Factors for Locally Recurrent Rectal Cancer Treated With Proton Beam Therapy

Sung, 2021, Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 71, 209, 10.3322/caac.21660 Sauer, 2004, Preoperative versus postoperative chemoradiotherapy for rectal cancer, N Engl J Med, 351, 1731, 10.1056/NEJMoa040694 Bonnetain, 2012, What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: Surrogacy in question?, Eur J Cancer, 48, 1781, 10.1016/j.ejca.2012.03.016 Sauer, 2012, Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: Results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years, J Clin Oncol, 30, 1926, 10.1200/JCO.2011.40.1836 Garcia-Aguilar, 2022, Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy, J Clin Oncol, 40, 10.1200/JCO.22.00032 Jayne, 2010, Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer, Br J Surg, 97, 1638, 10.1002/bjs.7160 Bhangu, 2014, Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer, Ann Surg, 259, 315, 10.1097/SLA.0b013e31828a0d22 2018, Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer, Br J Surg, 105, 650, 10.1002/bjs.10734 Bhangu, 2012, Meta-analysis of survival based on resection margin status following surgery for recurrent rectal cancer, Colorectal Dis, 14, 1457, 10.1111/j.1463-1318.2012.03005.x Nielsen, 2012, A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database, Colorectal Dis, 14, 1076, 10.1111/j.1463-1318.2011.02893.x Nielsen, 2015, Early and late outcomes of surgery for locally recurrent rectal cancer: A prospective 10-year study in the total mesorectal excision era, Ann Surg Oncol, 22, 2677, 10.1245/s10434-014-4317-y Young, 1999, Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: Review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group, Eur J Cancer, 35, 1773, 10.1016/S0959-8049(99)00229-4 Tanaka, 2017, Radiotherapy for locally recurrent rectal cancer treated with surgery alone as the initial treatment, Radiat Oncol J, 35, 71, 10.3857/roj.2016.02005 Cai, 2015, CAPIRI-IMRT: A phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer, Radiat Oncol, 10, 57, 10.1186/s13014-015-0360-5 Kim, 2008, Stereotactic body radiation therapy in patients with pelvic recurrence from rectal carcinoma, Jpn J Clin Oncol, 38, 695, 10.1093/jjco/hyn083 Hamauchi, 2012, Safety and efficacy of proton-beam radiation therapy for patients with locally recurrent rectal cancer, Ann Oncol, 23, xi160, 10.1016/S0923-7534(20)32506-0 Hiroshima, 2021, Proton beam therapy for local recurrence of rectal cancer, Anticancer Res, 41, 3589, 10.21873/anticanres.15147 Yamada, 2016, Carbon-ion radiation therapy for pelvic recurrence of rectal cancer, Int J Radiat Oncol Biol Phys, 96, 93, 10.1016/j.ijrobp.2016.04.022 Shinoto, 2019, Carbon-ion radiotherapy for locally recurrent rectal cancer: Japan Carbon-ion Radiation Oncology Study Group (J-CROS) Study 1404 Rectum, Radiother Oncol, 132, 236, 10.1016/j.radonc.2018.10.007 Uemura, 2021, The efficiency of (18)F-FDG-PET/CT in the assessment of tumor response to preoperative chemoradiation therapy for locally recurrent rectal cancer, BMC Cancer, 21, 1132, 10.1186/s12885-021-08873-7